Elizabeth Mumper, United States of America

Rimland Center for Integrative Medicine Advocates for Children
Dr. Mumper is CEO of The Rimland Center, established to mentor clinicians interested in children with neurodevelopmental problems. My general pediatrics practice is Advocates for Children. Advocates for Families is devoted to the care of children with autism and other neurodevelopmental problems. I attended the Medical College of Virginia, did residency training at the University of Massachusetts and University of Virginia, where I served as Chief Resident of Pediatrics at UVA. My clinical experience has included five years in pediatric practice, over a decade as Director of Pediatric Education in a Family Practice Residency Program, 16 years as clinical faculty at the University of Virginia, and five years as Medical Director of the Autism Research Institute. Dr. Mumper has written book chapters about allergy, immunology and behavioral and developmental pediatrics. My clinical research at the Rimland Center has been published in peer reviewed journals. I lecture nationally and internationally about the medical problems of children with neurodevelopmental disorders and strategies to prevent chronic illness. I am currently doing research about vaccination status as it relates to the prevalence of chronic illness in children. I advocate integrative and functional medicine strategies to care for children with complex chronic illness.

Presenter of 1 Presentation

 Conference Calendar

VACCINATION PRACTICES AND CHRONIC DISEASE STATUS IN A COHORT OF PEDIATRIC PATIENTS IN THE UNITED STATES

Session Name
PS18 - VACCINE AND AUTOIMMUNITY
Session Type
PARALLEL SESSIONS
Date
29.05.2021, Saturday
Session Time
15:30 - 17:30
Room
HALL F
Lecture Time
16:30 - 16:40
Presenter
Session Icon
Pre Recorded

Abstract

Background and Aims

CDC and AAP recommend a standard immunization schedule for all children. Variations in the schedule due to concurrent illness, parental preference or immune dysregulation are discouraged. We hypothesize that children are healthier when they are not subjected to “one size fits all” vaccine policies.

Methods

Comprehensive data on 2,590 patients from a pediatric practice allowing modified vaccine schedules were analyzed for multiple outcomes with regards to immunization status. Patients defined as “inborn” were seen by our practice during the first 28 days of life. Real-world data include all sources of variability affecting disease rates, which clinical trials do not.

Results

Inborn patients received vaccines on a modified schedule that recommended hepatitis B vaccine at age 3 or above (unless mom positive), and MMR vaccine at age 2 for most children (3 for African American children). We did not recommend rotavirus or Gardasil vaccines. Inborn patients received fewer vaccines simultaneously (1 or 2 injections) than outborn patients.

Likelihood of developing autism was statistically significantly higher for outborn (6.3%) than for inborn patients following a modified schedule (0.52%). CDC surveillance autism rates were 1-3% during study period.

Likelihood of developing asthma was statistically significantly higher for outborn (6.3%) than for inborn patients (0.1%).

Conclusions

Patients given an alternative vaccine schedule since birth demonstrated significantly lower incidences of autism and asthma, providing evidence for re-evaluation of temporal association between vaccines and important chronic illnesses. Similar results are being analyzed on a cohort of more than 20,000 patients.

Hide